Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06492694 · ClinicalTrials.gov registry record · NA
Omega-3 Supplement and Health Markers
A NA study, sponsored by dōTERRA International.
- Completed
- Registry status
- NA
- Development phase
- 55
- Enrollment target
NCT06492694: Completed NA study, sponsored by dōTERRA International.
NCT06492694 is a NA study that has completed, run by dōTERRA International. The registered enrollment target is 55 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06492694, a NA study, has completed, sponsored by dōTERRA International.
- COMPLETED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn whether fish oil-based supplements can affect gene expression and serum protein markers in healthy volunteers. The main questions it aims to answer are: 1. How does daily ingestion of fish oil supplements affect gene expression, omega-3 levels, and protein markers as measured in blood? 2. How does daily ingestion of fish oil supplements affect anthropometric measurements? 3. How does daily ingestion of fish oil supplements affect subjective quality of life and health parameters? 4. Do fish oil + wild orange essential oil supplements produce different outcomes than fish oil supplements alone? 5. Is ingesting fish oil supplements daily safe, as measured by laboratory tests and adverse events? Researchers will compare two types of fish oil supplements. One type contains fish oil and wild orange essential oil as its active ingredients. The other type contains only fish oil as its active ingredient. Participants will: * Be assigned one of the two types of fish oil supplements * Take three softgels of their assigned supplement every day for about six weeks * Attend two study visits in which they provide blood and urine samples, complete subjective health and quality of life assessments, and undergo anthropometric measurements * Complete weekly subjective health assessments from home
Primary Outcome
Gene expression analysis refers to a genome-wide quantification of methylation. EPIC850k array will be used for methylation analysis. This represents approximately 900,000 gene locations. The main feature performed is a differential methylation analysis to determine what has significantly changed from one time point to another.
Interventions
- DIETARY_SUPPLEMENT Fish oil + wild orange essential oil supplement
- DIETARY_SUPPLEMENT Fish oil supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2024-06-10 |
| Est. Completion | 2024-09-03 |
| Phase | NA |
What the finished NCT06492694 record still lists
NCT06492694 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 55 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Fish oil + wild orange essential oil supplement is the first listed.
NCT06492694 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06492694 about?
NCT06492694 is a clinical study titled "Omega-3 Supplement and Health Markers". The goal of this clinical trial is to learn whether fish oil-based supplements can affect gene expression and serum protein markers in healthy volunteers. The main questions it aims to answer are: 1. How does daily ingestion of fish oil supplements affect gene expression, omega-3 levels, and protei...
What is the current status of trial NCT06492694?
This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2024-06-10. Estimated completion is 2024-09-03.
What interventions are being tested in trial NCT06492694?
The interventions under investigation include: Fish oil + wild orange essential oil supplement (DIETARY_SUPPLEMENT), Fish oil supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06492694?
This trial is sponsored by dōTERRA International, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06492694's enrollment target sits among peer trials
55 1264th of 2000 higher than 733 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI